40mg required, 5mg in bottle – Improves memory Source
improves cognitive decline in impaired cognition patients Source
Improvement in Cognition Speed (note: branded study) Source
Improves reaction time, decisions time, and movement times Source
BACOPA MONNIERI, ONE OF OUR ACTIVE INGREDIENTS, IS MORE EFFECTIVE OVER TIME. SCIENTIFIC STUDIES HAVE SHOWN THAT IT’S EFFECTS ARE MORE PRONOUNCED AT 12 WEEKS COMPARED TO 4 WEEKS SOURCE
- Improved speed of visual information processing, learning rate, and memory consolidation (Bacopa Monnieri) Source
- Enhance memory and learning performance (Huperzine A) Source
IT HAS BEEN REFERRED TO AS “NATURE’S VALIUM” BECAUSE OF THE CALMING EFFECT IT CAN EXERT
- Relieving anxiety
- Improving mood
- Reducing symptoms of Premenstrual Syndrome (PMS)
- And treating attention deficit-hyperactivity disorder (ADHA) Source
Research suggests that taking Huperzine for up to 8 weeks may improve memory, mental function, and behavior in people with conditions such as Alzheimer’s and Dementia. Source
helps protect the brain from both age-related and stress-related damage to the brain which helps it function longer and better. Carnitine also plays a critical role in energy production. It transports long-chain fatty acids into the mitochondria so they can be oxidized (“burned”) to produce energy. Source
Source: Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer’s disease. Int Clin Psychopharmacol 2003;18:61-71.
Ames BN, Liu J. Delaying the mitochondrial decay of aging with acetylcarnitine. Ann NY Acad Sci 2004;1033:108-16.
Rebouche CJ. Carnitine. In: Modern Nutrition in Health and Disease, 9th Edition (edited by Shils ME, Olson JA, Shike M, Ross, AC). Lippincott Williams and Wilkins, New York, 1999, pp. 505-12.
The editors. Carnitine: lessons from one hundred years of research. Ann NY Acad Sci 2004;1033:ix-xi..
Studies show that Vitamin B may slow brain shrinkage up to 90 percent including areas of the brain shown to be most impacted by Alzheimer’s Disease and reduce memory loss. Source
IS OFTEN USED FOR MEMORY DISORDERS INCLUDING ALZHEIMER’S DISEASE. IT IS ALSO USED FOR CONDITIONS THAT RELATE TO REDUCED BLOOD FLOW IN THE BRAIN ESPECIALLY IN OLDER PEOPLE. THESE CONDITIONS INCLUDE: